ID   WHIRC01
AC   CVCL_LB55
SY   Women's Health Integrated Research Center 01
DR   cancercelllines; CVCL_LB55
DR   Wikidata; Q54994000
RX   PubMed=28251557;
CC   Characteristics: Derived from a patient-derived mouse xenograft.
CC   Doubling time: ~30 hours (PubMed=28251557).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gly (c.742C>G); ClinVar=VCV000376652; Zygosity=Unspecified (PubMed=28251557).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=28251557
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
RX   PubMed=28251557; DOI=10.1007/s13577-017-0162-1;
RA   Teng P.-N., Bateman N.W., Wang G.-S., Litzi T., Blanton B.E., Hood B.L.,
RA   Conrads K.A., Ao W., Oliver K.E., Darcy K.M., McGuire W.P., Paz K.,
RA   Sidransky D., Hamilton C.A., Maxwell G.L., Conrads T.P.;
RT   "Establishment and characterization of a platinum- and
RT   paclitaxel-resistant high grade serous ovarian carcinoma cell line.";
RL   Hum. Cell 30:226-236(2017).
//